Similarly, in our validation studies, THOR hypermethylation presented as a breast cancer signature and a potential regulatory mechanism of hTERT transcriptional activation since patients with higher THOR methylation levels exhibited the highest levels of hTERT expression (Fig. 2 and Figure S1). The gene discussed is THORLNC; the disease is breast carcinoma.